China slaps down local biotech over claims it could produce Gilead’s experimental coronavirus drug By: MarketWatch March 02, 2020 at 10:27 AM EST Chinese biotech BrightGene has been reprimanded for claims it could make coronavirus drug Read More >> Related Stocks: Gilead Sciences